Discover
SONN
Sonnet BioTherapeutics Holdings, Inc.
1.26
1 x 1.25
2 x 1.31
bid
ask
-
1.84
59.35%
04:00 PM
timesize
| Ytd | -13.70% | |
| 1y | -51.72% |
1.26
day range
3.23
1.42
52 week range
18.72
| Open | 3.16 | Prev Close | 3.10 | Low | 1.26 | High | 3.23 | Mkt Cap | 4.33M |
| Vol | 10.43M | Avg Vol | 1.33M | EPS | -11.35 | P/E | N/A | Forward P/E | -0.10 |
| Beta | 1.04 | Short Ratio | 0.03 | Inst. Own | 0.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.46 | 200-d Avg | 8.63 | 1yr Est | 160.00 |
| Income Statement | |||
| Operating Expenses | 3.81M | ||
| Research and Development Expense | 2.43M | ||
| Selling, General and Administrative Expense | 1.38M | ||
| Operating Income | -3.81M | ||
| Net Income | -3.78M | ||
| Net Income Common Stock | -3.78M | ||
| Net Income Common Stock (USD) | -3.78M | ||
| Consolidated Income | -3.78M | ||
| Earnings per Basic Share | -0.95 | ||
| Earnings per Basic Share (USD) | -0.95 | ||
| Earnings per Diluted Share | -0.95 | ||
| Earning Before Interest & Taxes (EBIT) | -3.78M | ||
| Earning Before Interest & Taxes (USD) | -3.78M | ||
| Weighted Average Shares | 3.97M | ||
| Weighted Average Shares Diluted | 3.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 321.30K | ||
| Cash and Equivalents (USD) | 321.30K | ||
| Current Assets | 1.32M | ||
| Property, Plant & Equipment Net | 77.49K | ||
| Total Assets | 2.06M | ||
| Debt Current | 68.84K | ||
| Total Debt | 68.84K | ||
| Current Liabilities | 5.10M | ||
| Total Liabilities | 5.10M | ||
| Accumulated Retained Earnings (Deficit) | -128.11M | ||
| Shareholders Equity | -3.05M | ||
| Shareholders Equity (USD) | -3.05M | ||
| Assets Non-Current | 735.78K | ||
| Total Debt (USD) | 68.84K | ||
| Trade and Non-Trade Payables | 3.75M | ||
| Tax Assets | 597.39K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.16K | ||
| Net Cash Flow from Financing | 21.05K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.74M | ||
| Issuance (Purchase) of Equity Shares | 41.05K | ||
| Net Cash Flow from Operations | -1.76M | ||